1. "Biostatistics Service"
Formats
  1. Journal Article (3978)
  2. Meeting Abstract (2395)
  3. Research Letter (51)
  4. Conference Paper (37)
  5. Correspondence (26)
  6. Editorial (25)
  7. Review (21)
  8. Miscellaneous (14)
  9. Book Section (13)
  10. Book Whole (3)
  11. Guidelines (2)
Groups
  1. Biostatistics Service (6565)
  2. Epidemiology and Biostatistics (6565)
  3. Department of Medicine (3849)
  4. Solid Tumor Oncology Division (2571)
  5. Survivorship Research (2488)
  6. Surgery (2392)

More Groups

People
  1. Mithat Gonen (1028)
  2. Sean Devlin (601)
  3. Katherine Panageas (512)
  4. Sujata Patil (511)
  5. Sergio Giralt (465)
  6. Zhigang Zhang (427)

More People

Years
  1. 2025 (119)
  2. 2024 (362)
  3. 2023 (411)
  4. 2022 (407)
  5. 2021 (369)
  6. 2020 (394)

More Years

Publications
  1. Journal of Clinical Oncology (1058)
  2. Blood (432)
  3. Annals of Surgical Oncology (308)
  4. International Journal of Radiation Oncology, Biology, Physics (233)
  5. Clinical Cancer Research (195)
  6. Biology of Blood and Marrow Transplantation (174)

More Publications

Publishers
  1. American Society of Clinical Oncology (1124)
  2. Elsevier Inc. (930)
  3. Springer (625)
  4. American Society of Hematology (486)
  5. American Association for Cancer Research (430)
  6. Nature Publishing Group (311)

More Publishers

Results (6565)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The interaction of radiation, the ATM gene and breast cancer
    Meeting Abstract

    Bernstein, J.; Bernstein, L.; Langholz, B.; Thomas, D.; Stovall, M.; Capanu, M.; Thompson, W. D.; Olson, J.; Malone, K.; Lynch, C.; more...
    American Journal of Epidemiology (2006)

    Fulltext@MSK | Save
  • Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events
    Meeting Abstract

    Basch, E. M.; McDonough, T.; Iasonos, A.; Siegel, E.; Culkin, A.; Kris, M.; Scher, H. I.; Schrag, D.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): Impact on prognostic factors and outcome
    Meeting Abstract

    Barbour, A. P.; Rizk, N.; Gonen, M.; Bains, M.; Rusch, V.; Coit, D.; Brennan, M. F.
    Annals of Surgical Oncology (2006)

    Fulltext@MSK | Save
  • Phase I pharmacokinetic (PK) and pharmacodynamic (PD) study of 17-Allylamino-17-demethoxygeldanamycin (17AAG) in children with solid tumors
    Meeting Abstract

    Bagatell, R.; Gore, L.; Egorin, M.; Ho, R.; Boucher, N.; Heller, G.; Trippett, T.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Interim results of two prospective trials measuring plasma total DNA and methylated genes before and after surgery, or chemotherapy, in patients with non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Azzoli, C. G.; Park, S.; Ginex, P.; Vincent, A.; Jones, J.; Venkatraman, E.; Danenberg, K.; Danenberg, P.; Rusch, V. R.; Kris, M. G.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Response to neoadjuvant chemotherapy as measured by PET predicts outcome after liver resection for colorectal metastases
    Meeting Abstract

    Akhurst, T. J.; Gonen, M.; Tuorto, S.; Schwartz, L.; Brody, L.; Larson, S. M.; Fong, Y.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Prognostic model for primary CNS lymphoma (PCNSL): Recursive partitioning analysis (RPA) of the MSKCC PCNSL population
    Meeting Abstract

    Abrey, L. E.; BenPorat, L.; Panageas, K. S.; Yahalom, J.; Deangelis, L. M.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • A non-randomized phase II study of sequential irinotecan (CPT) and flavopiridol (F) in patients (pts) with advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Abou-Alfa, G. K.; Carvajal, R. D.; Chung, K. Y.; Ghossein, R. A.; Capanu, M.; Gonen, M.; Jacobs, G.; Kelsen, D. P.; Schwartz, G. K.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinorna
    Journal Article

    Shah, M. A.; Ramanathan, R. K.; Ilson, D. H.; Levnor, A.; D'adamo, D.; O'reilly, E.; Tse, A.; Trocola, R.; Schwartz, L.; Capanu, M.; more...
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas
    Journal Article

    Pham, D. K.; Kris, M. G.; Riely, G. J.; Sarkaria, I. S.; McDonough, T.; Chuai, S. K.; Venkatraman, E. S.; Miller, V. A.; Ladanyi, M.; Pao, W.; more...
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save